Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, USA.
Am Surg. 2023 Jun;89(6):2445-2449. doi: 10.1177/00031348221101473. Epub 2022 May 11.
Laparoscopic Heller myotomy (LHM) and esophageal balloon dilation (BD) are the two mainstays of achalasia treatment-this study examines the outcomes when they are performed simultaneously without fundoplication.
All patients undergoing LHM&BD were reviewed for demographic and procedural data, and to see if additional procedures for achalasia had been performed. Patients were surveyed using the Eckardt score and the GERD quality-of-life score (GERD-HRQL) to assess the durability of repair.
From 2013-2020, 66 patients underwent LHM&BD. There were no esophageal perforations and a median LOS of 1 day. Seven patients have required additional operations or procedures at median 4-years follow up. 31 patients (47%) responded to the survey. The average Eckardt score was 2.9 (goal<4) with mean GERD-HRQL of 14.4 (goal<25).
LHM&BD allows for a safe, durable repair of achalasia. Reflux symptoms are manageable with PPI without fundoplication and the re-intervention rate similar to published values.
腹腔镜 Heller 肌切开术(LHM)和食管气囊扩张术(BD)是治疗贲门失弛缓症的两种主要方法-本研究探讨了在不进行胃底折叠术的情况下同时进行这两种方法的治疗效果。
回顾性分析了所有接受 LHM&BD 的患者的人口统计学和手术数据,并观察是否对贲门失弛缓症进行了其他治疗。通过 Eckardt 评分和 GERD 生活质量评分(GERD-HRQL)对患者进行调查,以评估修复的耐久性。
2013 年至 2020 年,66 例患者接受了 LHM&BD。没有发生食管穿孔,中位 LOS 为 1 天。7 例患者在中位随访 4 年后需要进行额外的手术或治疗。31 例(47%)患者对调查做出了回应。平均 Eckardt 评分为 2.9(目标<4),平均 GERD-HRQL 为 14.4(目标<25)。
LHM&BD 可安全、持久地治疗贲门失弛缓症。在不进行胃底折叠术的情况下,使用 PPI 可控制反流症状,且再干预率与已发表的值相似。